1. Home
  2. CERO vs TIVC Comparison

CERO vs TIVC Comparison

Compare CERO & TIVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • TIVC
  • Stock Information
  • Founded
  • CERO 2017
  • TIVC 2016
  • Country
  • CERO United States
  • TIVC United States
  • Employees
  • CERO N/A
  • TIVC N/A
  • Industry
  • CERO
  • TIVC Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • CERO
  • TIVC Health Care
  • Exchange
  • CERO Nasdaq
  • TIVC Nasdaq
  • Market Cap
  • CERO 5.6M
  • TIVC 4.9M
  • IPO Year
  • CERO N/A
  • TIVC 2021
  • Fundamental
  • Price
  • CERO $5.43
  • TIVC $3.04
  • Analyst Decision
  • CERO Strong Buy
  • TIVC
  • Analyst Count
  • CERO 2
  • TIVC 0
  • Target Price
  • CERO $45.00
  • TIVC N/A
  • AVG Volume (30 Days)
  • CERO 306.0K
  • TIVC 834.1K
  • Earning Date
  • CERO 08-22-2025
  • TIVC 11-13-2025
  • Dividend Yield
  • CERO N/A
  • TIVC N/A
  • EPS Growth
  • CERO N/A
  • TIVC N/A
  • EPS
  • CERO N/A
  • TIVC N/A
  • Revenue
  • CERO N/A
  • TIVC $462,000.00
  • Revenue This Year
  • CERO N/A
  • TIVC N/A
  • Revenue Next Year
  • CERO N/A
  • TIVC N/A
  • P/E Ratio
  • CERO N/A
  • TIVC N/A
  • Revenue Growth
  • CERO N/A
  • TIVC N/A
  • 52 Week Low
  • CERO $4.27
  • TIVC $2.43
  • 52 Week High
  • CERO $895.40
  • TIVC $15.64
  • Technical
  • Relative Strength Index (RSI)
  • CERO 32.53
  • TIVC 42.79
  • Support Level
  • CERO $4.27
  • TIVC $2.81
  • Resistance Level
  • CERO $5.65
  • TIVC $3.05
  • Average True Range (ATR)
  • CERO 0.54
  • TIVC 0.12
  • MACD
  • CERO -0.17
  • TIVC 0.03
  • Stochastic Oscillator
  • CERO 31.12
  • TIVC 60.53

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.

About TIVC Tivic Health Systems Inc.

Tivic Health Systems Inc is a health technology company focused on developing and commercializing non-invasive bioelectronic medicine. The company's platform-based technology activates the body's own healing mechanisms and can be programmed to treat various disease conditions. company's products provide a natural alternative to the standard synthetic chemical methods used by the pharmaceutical industry. ClearUP Sinus Relief, is a first commercial product of the company which is a patented handled device that uses ultra-low current electrical waves to relieve sinus pain and congestion symptoms that are prevalent in nasal allergies, sinus infections, chronic sinusitis, cold and flu and other disease conditions.

Share on Social Networks: